238 related articles for article (PubMed ID: 34217135)
1. Natural killer cells and unconventional T cells in COVID-19.
Björkström NK; Ponzetta A
Curr Opin Virol; 2021 Aug; 49():176-182. PubMed ID: 34217135
[TBL] [Abstract][Full Text] [Related]
2. Unconventional T cells - New players in antifungal immunity.
Dunne MR; Wagener J; Loeffler J; Doherty DG; Rogers TR
Clin Immunol; 2021 Jun; 227():108734. PubMed ID: 33895356
[TBL] [Abstract][Full Text] [Related]
3. Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression.
Stolk D; van der Vliet HJ; de Gruijl TD; van Kooyk Y; Exley MA
Front Immunol; 2018; 9():1990. PubMed ID: 30298063
[TBL] [Abstract][Full Text] [Related]
4. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients.
Deschler S; Kager J; Erber J; Fricke L; Koyumdzhieva P; Georgieva A; Lahmer T; Wiessner JR; Voit F; Schneider J; Horstmann J; Iakoubov R; Treiber M; Winter C; Ruland J; Busch DH; Knolle PA; Protzer U; Spinner CD; Schmid RM; Quante M; Böttcher K
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546489
[TBL] [Abstract][Full Text] [Related]
5. The role of unconventional T cells in COVID-19.
Orumaa K; Dunne MR
Ir J Med Sci; 2022 Apr; 191(2):519-528. PubMed ID: 34050887
[TBL] [Abstract][Full Text] [Related]
6. Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients.
Wang X; Bai H; Ma J; Qin H; Zeng Q; Hu F; Jiang T; Mao W; Zhao Y; Chen X; Qi X; Li M; Xu J; Hao J; Wang Y; Ding X; Liu Y; Huang T; Fang C; Ge C; Li D; Hu K; Ren X; Zhang B; Zhang B; Shi B; Zhang C
Front Immunol; 2022; 13():812514. PubMed ID: 35281000
[TBL] [Abstract][Full Text] [Related]
7. Unbiased Profiling Reveals Compartmentalization of Unconventional T-Cells Within the Intestinal Mucosa Irrespective of HIV Infection.
Magnoumba M; Singh A; Ogongo P; Roider J; Asowata O; Fehlings M; Karim F; Ndung'u T; Anderson F; Leslie A; Kløverpris H
Front Immunol; 2020; 11():579743. PubMed ID: 33117384
[TBL] [Abstract][Full Text] [Related]
8. Tissue-resident lymphocytes: from adaptive to innate immunity.
Sun H; Sun C; Xiao W; Sun R
Cell Mol Immunol; 2019 Mar; 16(3):205-215. PubMed ID: 30635650
[TBL] [Abstract][Full Text] [Related]
9. Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.
Dias J; Leeansyah E; Sandberg JK
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5434-E5443. PubMed ID: 28630305
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients.
Jouan Y; Guillon A; Gonzalez L; Perez Y; Boisseau C; Ehrmann S; Ferreira M; Daix T; Jeannet R; François B; Dequin PF; Si-Tahar M; Baranek T; Paget C
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32886755
[TBL] [Abstract][Full Text] [Related]
11. Immune Response in Severe and Non-Severe Coronavirus Disease 2019 (COVID-19) Infection: A Mechanistic Landscape.
Mukund K; Nayak P; Ashokkumar C; Rao S; Almeda J; Betancourt-Garcia MM; Sindhi R; Subramaniam S
Front Immunol; 2021; 12():738073. PubMed ID: 34721400
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Transcriptomic Profiling of MAIT Cells in Patients With COVID-19.
Shi J; Zhou J; Zhang X; Hu W; Zhao JF; Wang S; Wang FS; Zhang JY
Front Immunol; 2021; 12():700152. PubMed ID: 34394094
[TBL] [Abstract][Full Text] [Related]
13. Stress-elicited glucocorticoid receptor signaling upregulates TIGIT in innate-like invariant T lymphocytes.
Rudak PT; Gangireddy R; Choi J; Burhan AM; Summers KL; Jackson DN; Inoue W; Haeryfar SMM
Brain Behav Immun; 2019 Aug; 80():793-804. PubMed ID: 31108170
[TBL] [Abstract][Full Text] [Related]
14. Behaviors of Human T cells in SARS-CoV-2 Infection: Lessons and Tips.
Shams A; Khosravi S; Zareiye A; Lalehzari Y; Nematollahi R; Basti S
Iran J Immunol; 2023 Dec; 20(4):382-399. PubMed ID: 37842930
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
[TBL] [Abstract][Full Text] [Related]
16. Human blood MAIT cell subsets defined using MR1 tetramers.
Gherardin NA; Souter MN; Koay HF; Mangas KM; Seemann T; Stinear TP; Eckle SB; Berzins SP; d'Udekem Y; Konstantinov IE; Fairlie DP; Ritchie DS; Neeson PJ; Pellicci DG; Uldrich AP; McCluskey J; Godfrey DI
Immunol Cell Biol; 2018 May; 96(5):507-525. PubMed ID: 29437263
[TBL] [Abstract][Full Text] [Related]
17. MAIT Cells in COVID-19: Heroes, Villains, or Both?
Haeryfar SMM
Crit Rev Immunol; 2020; 40(2):173-184. PubMed ID: 32749095
[TBL] [Abstract][Full Text] [Related]
18. Invariant Natural Killer T and Mucosal-Associated Invariant T Cells in Asthmatic Patients.
Lezmi G; Leite-de-Moraes M
Front Immunol; 2018; 9():1766. PubMed ID: 30105031
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in
Ellsworth CR; Wang C; Katz AR; Chen Z; Islamuddin M; Yang H; Scheuermann SE; Goff KA; Maness NJ; Blair RV; Kolls JK; Qin X
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
